DEFINITIVE PROXY STATEMENT

Company

Lineage Cell Therapeutics, Inc.

Filed

June 11, 1999

Period of Report

December 31, 1998

Accession Number

0000876343-99-000018

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →